Heinz Kurz GmbH Medizintechnik

Breathe Implant àWengen

The nasal valve contributes 50% of total airway resistance within the respiratory tract when it is functioning normally. When nasal valve narrowing or inspiratory collapse are present, serious respiratory insufficiencies are the result.

To achieve consistent correction of nasal valvular dysfunction caused by aging, trauma, prior rhinoplasty, and septal anomalies, the Breathe Implant àWengen dilates the nasal valve and permanently stabilizes the lateral soft tissue.

In open rhinoplastic surgery, the Breathe Implant àWengen is placed on the upper lateral cartilage, fixed with non-resorbable sutures and partially covered with the lower lateral cartilage. Four implant sizes fit most anatomic, ethnologic and age-dependent physical variations. Corresponding sizers facilitate the surgeon’s selection of the appropriate model for each patient.

Benefits

• Positioning the implant between the upper and lower lateral cartilages stabilizes implant position
• The standardized method simplifies and shortens the procedure; implants are pre-shaped and require minimal or no contouring
• Placing the implant between upper and lower lateral cartilages minimizes risk of hump formation, infection, or extrusion
• Non-resorbable suture fixation significantly decreases the potential for implant dislocation
• Holes in titanium reduce risk of tissue necrosis
• Uniform geometry and material thickness achieve predefined (minimum-to-maximum) stress ratios
• Minimal discernible cosmetic deformity due to small diameter of 0.5 mm
• MRT safe (7.0 T)

Ordering information: